CareDx (CDNA) Tops Q1 EPS by 21c; Withdraws Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
BTIG Downgrades CareDx, Inc (CDNA) to Neutral 'Given various uncertainties'
May 11, 2023 6:14 AM EDTBTIG analyst Sung Ji Nam downgraded CareDx, Inc (NASDAQ: CDNA) from Buy to Neutral.
The analyst comments "CareDx announced on its Q1 call that they are withdrawing its guidance, which is more Draconian than we called for in our preview for CDNA to... More
